AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI)
CUSIP: 00901B105
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 67,129,058
- Total 13F shares
- 3,129,359
- Share change
- +367,567
- Total reported value
- $5,599,408
- Price per share
- $1.79
- Number of holders
- 29
- Value change
- +$598,092
- Number of buys
- 13
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 00901B105?
CUSIP 00901B105 identifies AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00901B105:
Top shareholders of AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
805,415
|
$1,732,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.75%
|
502,692
|
$1,080,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.6%
|
404,953
|
$870,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
221,489
|
$476,000 | — | 30 Sep 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.17%
|
116,800
|
$251,000 | — | 30 Sep 2020 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.14%
|
95,754
|
$206,000 | — | 30 Sep 2020 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.1%
|
70,000
|
$151,000 | — | 30 Sep 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.1%
|
65,266
|
$140,000 | — | 30 Sep 2020 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.08%
|
50,515
|
$109,000 | — | 30 Sep 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.06%
|
42,738
|
$92,000 | — | 30 Sep 2020 | |
| Bayesian Capital Management, LP |
13F
|
Company |
0.06%
|
42,200
|
$91,000 | — | 30 Sep 2020 | |
| Verition Fund Management LLC |
13F
|
Company |
0.06%
|
40,000
|
$86,000 | — | 30 Sep 2020 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.05%
|
34,179
|
$73,000 | — | 30 Sep 2020 | |
| Virtu Financial LLC |
13F
|
Company |
0.04%
|
29,604
|
$64,000 | — | 30 Sep 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
28,003
|
$60,000 | — | 30 Sep 2020 | |
| Arkadios Wealth Advisors |
13F
|
Company |
0.03%
|
20,000
|
$45,400 | — | 30 Sep 2020 | |
| LPL Financial LLC |
13F
|
Company |
0.03%
|
20,500
|
$44,000 | — | 30 Sep 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
20,316
|
$44,000 | — | 30 Sep 2020 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.03%
|
20,000
|
$43,000 | — | 30 Sep 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
17,715
|
$38,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
17,367
|
$37,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
16,710
|
$36,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
16,553
|
$36,000 | — | 30 Sep 2020 | |
| Traynor Capital Management, Inc. |
13F
|
Company |
0.02%
|
14,777
|
$31,000 | — | 30 Sep 2020 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.02%
|
13,295
|
$29,000 | — | 30 Sep 2020 | |
| XTX MARKETS LLC |
13F
|
Company |
0.02%
|
11,873
|
$26,000 | — | 30 Sep 2020 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.02%
|
11,600
|
$25,000 | — | 30 Sep 2020 | |
| Advisory Services Network, LLC |
13F
|
Company |
0%
|
1,250
|
$3,000 | — | 30 Sep 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
406
|
$1,000 | — | 30 Sep 2020 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
228
|
$490 | — | 30 Sep 2020 |
Institutional Holders of AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) as of Q4 2020
As of 31 Dec 2020,
AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,129,359 shares.
The largest 10 holders included
MORGAN STANLEY, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, NORTHERN TRUST CORP, Verition Fund Management LLC, and SeaCrest Wealth Management, LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
30
Q4 2020 holders
29
Holder diff
-1
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.